1. Development of angiogenesis inhibitors for cancer therapy

   • S. Gail Eckhardt
   • James M. Pluda

   OriginalPaper Pages: 1 - 3

2. The preclinical evaluation of angiogenesis inhibitors

   • Michael S. O'Reilly

   OriginalPaper Pages: 5 - 13

3. Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy

   • Stephen B. Fox
   • Adrian L. Harris

   OriginalPaper Pages: 15 - 28

4. Angiogenic factors as tumor markers

   • Mai Nguyen

   OriginalPaper Pages: 29 - 37

5. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents

   • Yoshihiro Kakeji
   • Beverly A. Teicher

   OriginalPaper Pages: 39 - 48

6. An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action

   • William J. Gradishar

   OriginalPaper Pages: 49 - 59

7. Matrix metalloproteinase inhibitors

   • Slawomir M. Wojtowicz-Praga
   • Robert B. Dickson
   • Michael J. Hawkins

   OriginalPaper Pages: 61 - 75

8. Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action

   • Eugene A. Woltering
   • James C. Watson
   • Rosemary Barrie

   OriginalPaper Pages: 77 - 86